Page last updated: 2024-09-05

lenalidomide and Ambulation Disorders, Neurologic

lenalidomide has been researched along with Ambulation Disorders, Neurologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Steck, AJ1
Sucak, GT; Suyanı, E; Yağcı, M1

Reviews

1 review(s) available for lenalidomide and Ambulation Disorders, Neurologic

ArticleYear
Anti-MAG neuropathy: From biology to clinical management.
    Journal of neuroimmunology, 2021, 12-15, Volume: 361

    Topics: Adenine; Animals; Autoantibodies; Autoantigens; B-Lymphocyte Subsets; CD57 Antigens; Demyelinating Autoimmune Diseases, CNS; Epitopes; Gait Disorders, Neurologic; Humans; Immunosuppressive Agents; Immunotherapy; Lenalidomide; Mammals; Mice; Molecular Mimicry; Myelin Sheath; Myelin-Associated Glycoprotein; Nerve Fibers, Myelinated; Nervous System Autoimmune Disease, Experimental; Paraproteinemias; Paraproteins; Piperidines; Plasma Exchange; Polyradiculoneuropathy; Ranvier's Nodes; Rats; Rituximab

2021

Other Studies

1 other study(ies) available for lenalidomide and Ambulation Disorders, Neurologic

ArticleYear
Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome.
    Acta haematologica, 2011, Volume: 126, Issue:4

    Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Gait Disorders, Neurologic; Glucocorticoids; Hand Deformities, Acquired; Humans; Lenalidomide; POEMS Syndrome; Prednisolone; Proteasome Inhibitors; Remission Induction; Thalidomide; Vascular Endothelial Growth Factors

2011